QTXB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
QTXB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Quantrx Biomedical's General and Admin. Expense for the three months ended in Sep. 2022 was $0.01 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2022 was $0.05 Mil.
The historical data trend for Quantrx Biomedical's General and Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quantrx Biomedical Annual Data | |||||||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | |||||||||||
General and Admin. Expense | Get a 7-Day Free Trial | 0.15 | 0.24 | 0.20 | 0.06 | 0.04 |
Quantrx Biomedical Quarterly Data | ||||||||||||||||||||
Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | |
General and Admin. Expense | Get a 7-Day Free Trial | 0.01 | 0.01 | - | 0.03 | 0.01 |
General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.
General and Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Quantrx Biomedical's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael S Abrams | director | 64 RAMSHEAD ROAD, RAYNHAM MA 02767 |
Patrick T Mooney | director | C/O SONTRA MEDICAL CORPORATION, 10 FORGE PARKWAY, FRANKLIN MA 02038 |
Robert G. Pinco | director | 1700 K STREET NW, SUITE 300, WASHINGTON DC 20006 |
Hayes Arthur H Jr | director | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Matthew Balk | 10 percent owner | 229 WEST 60TH STREET, NEW YORK NY 10023 |
Evan Levine | director, 10 percent owner | 1517 SAN JACINTO ST., HOUSTON TX 77002 |
Hayes Arthur Hull Jr | director | C/O QUANTRX BIOMEDICAL CORPORATION, 100 S. MAIN STREET, SUITE 300, DOYLESTOWN PA 18901 |
Cindy Horton | officer: V.P. of Diagnostics | 209 BRITTANY PARK, ANDERSON SC 29621 |
Sasha Afanassiev | officer: Officer | 120 GARRISON COURT, LANGHORNE PA 19047 |
Shalom Hirschman | officer: Officer | 5240 BLACKSTONE AVENUE, RIVERDALE NY 10471 |
William H Fleming | director, officer: Secretary | |
Walter W Witoshkin | director, officer: President and CEO | 321 NORRISTOWN ROAD, SUITE 230, AMBLE PA 19002 |
Mark Capital Llc | 10 percent owner | 5173 SEAGROVE PLACE, SAN DIEGO CA 92130 |
Sherbrooke Partners, Llc | 10 percent owner | 570 LEXINGTON AVENUE, FLOOR 3, NEW YORK NY 10022 |
Goldman Sachs & Co. Llc | 10 percent owner | 200 WEST STREET, NEW YORK NY 10282 |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.